Fig. 11From: Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathwayProtein expression levels of the osteogenic markers HIF-1α and β-catenin in the bone tissue. Data are presented as the mean ± SD; *P < 0.05, **P < 0.01, compared with the sham group; #P < 0.05, ##P < 0.01, compared with the OVX groupBack to article page